Understanding How Glucocorticoids Work To Stop Skin Irritation
Main Category: DermatologyAlso Included In: Allergy; Immune System / Vaccines
Article Date: 21 Apr 2007 - 4:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
Individuals who are allergic to some things that their skin comes in contact with (a condition called contact dermatitis), such as metals or poison ivy, are treated with glucocorticoids, which can be applied to the skin as a cream or taken orally. Glucocorticoids work by dampening the inflammatory response to the allergen, but precisely which cells they affect and in what way have not been determined for contact dermatitis.
In a study appearing online in advance of publication in the May print issue of the Journal of Clinical Investigation, Gunther Schutz and colleagues from the German Cancer Research Institute, Heidelberg, show that glucocorticoids do not dampen inflammation induced by contact with an allergen in mice lacking expression of the glucocorticoid receptor in immune cells known as macrophages and neutrophils. Furthermore, for glucocorticoids to dampen inflammation the glucocorticoid receptor had to bind DNA and repress the production of several proinflammatory soluble factors, including IL-1-beta, MIP-2, MCP-1, and IP-10. Conversely, administration of these soluble factors to mice abrogated the protective effects of glucocoticoids following the induction of an allergic response in the skin. The authors therefore suggest that targeting macrophage and neutrophil production of these soluble factors might provide a more specific treatment for individuals with contact dermatitis than glucocorticoids and avoid the side-effects that are associated with long-term administration of glucocorticoids.
TITLE: Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy
AUTHOR CONTACT:
Gunther Schutz German Cancer Research Institute, Heidelberg, Germany.
Jan P. Tuckermann
Fritz Lipmann Institute, Jena, Germany.
Eberhard Fritz
Scientific Coordinator
Fritz Lipmann Institute, Jena, Germany
###
JCI table of contents -- April 19, 2007
Contact: Brooke Grindlinger
Journal of Clinical Investigation
Visit our dermatology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/68411.php>
APA
http://www.medicalnewstoday.com/releases/68411.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




